Microdialysis of triamcinolone acetonide in rat muscle.
The objective of this study was to compare plasma and muscle concentrations of triamcinolone acetonide (TA) in the rat by microdialysis. Microdialysis experiments were carried out at steady state in rats after an initial I.V. bolus 50 mg/kg of the phosphate ester of TA (TAP) followed by 23 mg/kg/h infusion. In vivo recovery was calculated by retrodialysis. The concentration determined at steady state in microdialysate, corrected for recovery, was 2.73 +/- 0.42 microg/mL compared to 21.9 +/- 2.3 microg/mL in plasma. The pharmacokinetics of TA in plasma was described by an open two-compartment model with a terminal half-life of 2.7 h. The clearance of TA in rats determined by compartmental analysis was 0.94 L/h/kg. The measured microdialysate levels of TA in muscle, corrected for recovery, were comparable to the predicted free drug levels in the peripheral compartment. Protein binding in rat plasma, measured by ultrafiltration, was 90.1%. The microdialysis in vivo recovery in muscle was similar to the in vitro recovery under stirred conditions. The results show the applicability of microdialysis to measure free tissue concentrations of TA in rats.
Rojas
Cioli
C
Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida 32610, USA.
Nagaraja
Nelamangala V
NV
Webb
Alistair I
AI
Derendorf
Hartmut
H
D000465:Algorithms; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000032:analysis*; D007262:Infusions, Intravenous; D008297:Male; D017551:Microdialysis; D008954:Models, Biological; D018482:Muscle, Skeletal / Q000737:chemistry*; D011485:Protein Binding; D051381:Rats; D017208:Rats, Wistar; D013056:Spectrophotometry, Ultraviolet; D014222:Triamcinolone Acetonide / Q000032:analysis*
D000893:Anti-Inflammatory Agents; D014222:Triamcinolone Acetonide